BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

March 20, 2018 11:06 PM UTC

In vitro and cell culture studies identified triazolopyrimidinone- and azabenzimidazole-based bacterial coaD inhibitors that could help treat Gram-negative bacterial infection. Fragment-based screenin...

BCIQ Company Profiles

Novartis AG